Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cutaneous emulsion | Is a | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
Cutaneous emulsion | Is a | emulsion | false | Inferred relationship | Some | ||
Cutaneous emulsion | Is a | Cutaneous dose form | true | Inferred relationship | Some | ||
Cutaneous emulsion | Has dose form administration method (attribute) | Apply (administration method) | true | Inferred relationship | Some | ||
Cutaneous emulsion | Has dose form intended site (attribute) | Cutaneous (intended site) | true | Inferred relationship | Some | ||
Cutaneous emulsion | Has dose form release characteristic (attribute) | Conventional release (release characteristic) | true | Inferred relationship | Some | ||
Cutaneous emulsion | Has basic dose form (attribute) | Emulsion | true | Inferred relationship | Some | ||
Cutaneous emulsion | Has dose form transformation (attribute) | No transformation | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous emulsion (clinical drug) | Has manufactured dose form | True | Cutaneous emulsion | Inferred relationship | Some | |
Hexachlorophene 30 mg/mL cutaneous emulsion | Has manufactured dose form | True | Cutaneous emulsion | Inferred relationship | Some | |
Benzyl benzoate 250 mg/mL cutaneous emulsion | Has manufactured dose form | True | Cutaneous emulsion | Inferred relationship | Some | |
Abametapir 7.4 mg/g cutaneous emulsion | Has manufactured dose form | True | Cutaneous emulsion | Inferred relationship | Some |
This concept is not in any reference sets